The efficacy of diabetes treatment should not be evaluated solely by HbA1c levels as\nthey should also focus on patient-reported outcomes (PROs), such as patient satisfaction, wellbeing\nand quality of life. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) has been developed\nto assess patient satisfaction with diabetes treatment. DTSQ has been translated into more than\n100 languages and is widely used in many countries, since it is relatively easy to answer and is\nused for both patients with and without medical therapy. Novel therapeutic options, such as insulin\nanalogs, incretin-based therapy and sodium-glucose cotransporter 2 (SGLT2) inhibitors, have been\nshown to improve patient satisfaction using DTSQ for assessments. DTSQ is not only used for\ncomparisons between different medications or treatment strategies, but also can be used to assess\nthe quality of diabetes care in clinical settings. This is important as an improvement in treatment\nsatisfaction may enhance patients� self-efficacy and adherence to therapy, leading to the achievement\nof long-term stable glycemic control and reduced risk of diabetic complications. In this review,\nwe summarize the current topics in DTSQ, introducing our own experience, and discuss the role of\nPROs in diabetes treatment.
Loading....